Description
Humana Press Inc. Hypertension And Hormone Mechanisms by Robert M. Carey
This book reviews novel developments in the endocrinology of hypertension with emphasis on new discovery during the past five years and perspectives on the future. It is written by authors who have spearheaded recent advances. With a focus on new developments in hormones and autacoids related to hypertension, the book provides a resource that will lead to new, active research in the fundamental mechanisms of hypertension._x000D_ _x000D_
Hypertension and Hormonal Mechanisms_x000D_
_x000D_
Chapter Outline_x000D_
_x000D_
(A) New Developments in the Renin-Angiotensin System_x000D_
_x000D_
1. The Intrarenal Renal-Angiotensin System _x000D_
Minolfa C. Prieto-Carrasquero, Hiroyuki Kobori and L. Gabriel Navar _x000D_
Tulane University_x000D_
_x000D_
2. Cardiac and Vascular Renin-Angiotensin Systems_x000D_
Rajesh Kumar, Kenneth M. Baker and Jing Pan_x000D_
Texas A & M University Health System_x000D_
_x000D_
3. Regulation of Cardiovascular Control Mechanisms by Angiotensin (1-7) _x000D_
and Angiotensin Converting Enzyme-2_x000D_
Carlos M. Ferrario, David B. Averill, K. Bridget Brosnihan, Mark C. Chappell, Debra I. Diz, Patriciai E. Gallagher, Liomar A.A. Neves and E. Ann Tallant_x000D_
Wake Forest University_x000D_
_x000D_
4. Angiotensin IV and the AT4 Receptor_x000D_
T. A. Jenkins, F.A.O. Mendelsohn, A.L. Albiston and S.Y. Chai_x000D_
Howard Florey Institute of Experimental Physiology and Medicine, Melbourne_x000D_
_x000D_
5. AT2 Receptors in Blood Pressure Regulation_x000D_
Robert M. Carey and Helmy M. Siragy _x000D_
University of Virginia Health System_x000D_
_x000D_
6. Angiotensin II and Inflammation_x000D_
Rhian M. Touyz and Ernesto L. Schiffrin_x000D_
Clinical Research Institute of Montreal_x000D_
_x000D_
7. Aldosterone and Vascular Damage_x000D_
Hilton V. Joffe, Gordon H. Williams and Gail K. Adler_x000D_
Harvard Medical School_x000D_
_x000D_
(B) The Sympatho-Adrenal System in Hypertension_x000D_
_x000D_
8. Neurogenic Human Hypertension_x000D_
David Robertson, Andre Diedrich and Italo Biaggioni_x000D_
Vanderbilt University_x000D_
_x000D_
9. Calcitonin Gene-Related Peptide and Hypertension_x000D_
Donald J. DiPette and Scott C. Supowit_x000D_
Texas A& M University_x000D_
_x000D_
10. The Renal Dopaminergic System in Hypertension_x000D_
Pedro A. Jose, Robert M. Carey and Robin A. Felder_x000D_
Georgetown University and the University of Virginia Health_x000D_
System_x000D_
_x000D_
(C) Metabolic Disorders and Hypertension_x000D_
_x000D_
11. The Insulin Resistance Syndrome and Hypertension_x000D_
James R. Sowers _x000D_
University of Missouri _x000D_
_x000D_
12. Fatty Acids and Hypertension_x000D_
Brent M. Egan_x000D_
Medical University of South Carolina_x000D_
_x000D_
13. Goal-Oriented Hypertension Management in Diabetic and Non-Diabetic _x000D_
Patients_x000D_
Gregory M. Singer, John F. Setaro and Henry R. Black_x000D_
Rush Presbyterian - St. Luke's Medical Cente_x000D_
_x000D_
(D) Endothelial Hormones and Autacoids and Hypertension_x000D_
_x000D_
14. Nitric Oxide and Hypertension_x000D_
David L. Mattson and Allen W. Cowley_x000D_
Medical College of Wisconsin_x000D_
_x000D_
15. Role of Endothelin 1 in Hypertension_x000D_
Ernesto L. Schiffrin_x000D_
Clinical Research Institute of Montreal_x000D_
_x000D_
16. The Kallekrein/Kinin System and Hypertension_x000D_
Julie Chao and Lee Chao_x000D_
Medical University of South Carolina_x000D_
_x000D_
(E) Other Hormonal Systems and Hypertension_x000D_
_x000D_
17. Natriuretic Peptides and Hypertension_x000D_
Kailesh N. Pandey_x000D_
Tulane University_x000D_
_x000D_
18. Sex Steroids and Hypertension_x000D_
Suzanne Oparil and Andrew Miller_x000D_
University of Alabama Birmingham_x000D_
_x000D_
19. The Lipoxygenase System in the Vasculature and Hypertension_x000D_
Naftali Stern and Michael Tuck_x000D_
Tel Aviv University and UCLA School of Medicine_x000D_